位置:首页 > 蛋白库 > FA50A_HUMAN
FA50A_HUMAN
ID   FA50A_HUMAN             Reviewed;         339 AA.
AC   Q14320; A8KAQ4; B2R997; Q5HY37; Q6PJH5;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2001, sequence version 2.
DT   03-AUG-2022, entry version 165.
DE   RecName: Full=Protein FAM50A;
DE   AltName: Full=Protein HXC-26;
DE   AltName: Full=Protein XAP-5;
GN   Name=FAM50A; Synonyms=DXS9928E, HXC26, XAP5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RX   PubMed=9339379; DOI=10.1006/geno.1997.4912;
RA   Mazzarella R., Pengue G., Yoon J., Jones J., Schlessinger D.;
RT   "Differential expression of XAP5, a candidate disease gene.";
RL   Genomics 45:216-219(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L.,
RA   Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C.,
RA   Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A.,
RA   Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P.,
RA   Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D.,
RA   Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D.,
RA   Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L.,
RA   Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P.,
RA   Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G.,
RA   Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J.,
RA   Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D.,
RA   Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L.,
RA   Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z.,
RA   Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O.,
RA   Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H.,
RA   Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T.,
RA   Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L.,
RA   Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R.,
RA   Gloeckner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y.,
RA   Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K.,
RA   Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J.,
RA   Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L.,
RA   Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S.,
RA   Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A.,
RA   Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L.,
RA   Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S.,
RA   Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., Mullikin J.C.,
RA   Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., Okwuonu G., Palmer S.,
RA   Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V.,
RA   Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K.,
RA   Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B.,
RA   Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C.,
RA   d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q.,
RA   Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N.,
RA   Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A.,
RA   Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J.,
RA   Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A.,
RA   Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L.,
RA   Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., Gibbs R.A., Beck S.,
RA   Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] OF 15-339.
RC   TISSUE=Skeletal muscle;
RX   PubMed=9039504; DOI=10.1093/dnares/3.5.337;
RA   Toyoda A., Sakai T., Sugiyama Y., Kusuda J., Hashimoto K., Maeda H.;
RT   "Isolation and analysis of a novel gene, HXC-26, adjacent to the rab GDP
RT   dissociation inhibitor gene located at human chromosome Xq28 region.";
RL   DNA Res. 3:337-340(1996).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 66-339.
RX   PubMed=8733135; DOI=10.1093/hmg/5.5.659;
RA   Chen E.Y., Zollo M., Mazzarella R.A., Ciccodicola A., Chen C.-N., Zuo L.,
RA   Heiner C., Burough F.W., Ripetto M., Schlessinger D., D'Urso M.;
RT   "Long-range sequence analysis in Xq28: thirteen known and six candidate
RT   genes in 219.4 kb of high GC DNA between the RCP/GCP and G6PD loci.";
RL   Hum. Mol. Genet. 5:659-668(1996).
RN   [8]
RP   PROTEIN SEQUENCE OF 159-170, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [11]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-100, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [12]
RP   FUNCTION, INTERACTION WITH EFTUD2 AND DDX41, TISSUE SPECIFICITY,
RP   SUBCELLULAR LOCATION, INVOLVEMENT IN MRXSA, VARIANTS MRXSA GLY-206;
RP   GLY-254; ASN-255; GLY-255 AND TRP-273, CHARACTERIZATION OF VARIANTS MRXSA
RP   GLY-206; GLY-254; ASN-255; GLY-255 AND TRP-273, AND CHARACTERIZATION OF
RP   VARIANTS VAL-137 AND LYS-143.
RX   PubMed=32703943; DOI=10.1038/s41467-020-17452-6;
RA   Lee Y.R., Khan K., Armfield-Uhas K., Srikanth S., Thompson N.A., Pardo M.,
RA   Yu L., Norris J.W., Peng Y., Gripp K.W., Aleck K.A., Li C., Spence E.,
RA   Choi T.I., Kwon S.J., Park H.M., Yu D., Do Heo W., Mooney M.R., Baig S.M.,
RA   Wentzensen I.M., Telegrafi A., McWalter K., Moreland T., Roadhouse C.,
RA   Ramsey K., Lyons M.J., Skinner C., Alexov E., Katsanis N., Stevenson R.E.,
RA   Choudhary J.S., Adams D.J., Kim C.H., Davis E.E., Schwartz C.E.;
RT   "Mutations in FAM50A suggest that Armfield XLID syndrome is a
RT   spliceosomopathy.";
RL   Nat. Commun. 11:3698-3698(2020).
CC   -!- FUNCTION: Probably involved in the regulation of pre-mRNA splicing.
CC       {ECO:0000269|PubMed:32703943}.
CC   -!- SUBUNIT: Interacts with EFTUD2, a component of the spliceosome U5
CC       complex (PubMed:32703943). Interacts with DDX41, a component of the
CC       spliceosome C complex (PubMed:32703943). {ECO:0000269|PubMed:32703943}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:32703943}.
CC   -!- TISSUE SPECIFICITY: Widely expressed in fetal and adult tissues. Mostly
CC       abundant in fetal brain, liver and kidney; in the adult, high levels
CC       were also observed in heart, skeletal muscle, spleen, thymus, prostate
CC       and small intestine. Expressed in fetal cerebellum and hypothalamus.
CC       Low expression is observed in fetal temporal lobe (PubMed:32703943).
CC       {ECO:0000269|PubMed:32703943, ECO:0000269|PubMed:9339379}.
CC   -!- DISEASE: Intellectual developmental disorder, X-linked, syndromic,
CC       Armfield type (MRXSA) [MIM:300261]: An X-linked recessive disorder
CC       characterized by global developmental delay with impaired intellectual
CC       development, walking difficulties and poor or absent speech. Affected
CC       individuals display a distinctive phenotype characterized by postnatal
CC       growth retardation, variable head circumference with a prominent
CC       forehead and dysmorphic facial features, ocular abnormalities, and
CC       seizures. {ECO:0000269|PubMed:32703943}. Note=The disease is caused by
CC       variants affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the FAM50 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AD001530; AAB81663.1; -; mRNA.
DR   EMBL; AK293119; BAF85808.1; -; mRNA.
DR   EMBL; AK313697; BAG36444.1; -; mRNA.
DR   EMBL; BX936365; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471172; EAW72708.1; -; Genomic_DNA.
DR   EMBL; BC000028; AAH00028.1; -; mRNA.
DR   EMBL; BC015499; AAH15499.1; -; mRNA.
DR   EMBL; D83389; BAA11907.1; -; Genomic_DNA.
DR   EMBL; D83260; BAA11871.1; -; mRNA.
DR   EMBL; L44140; AAA92649.1; -; Genomic_DNA.
DR   CCDS; CCDS14751.1; -.
DR   PIR; JC5276; JC5276.
DR   RefSeq; NP_004690.1; NM_004699.3.
DR   AlphaFoldDB; Q14320; -.
DR   BioGRID; 114578; 72.
DR   IntAct; Q14320; 7.
DR   MINT; Q14320; -.
DR   STRING; 9606.ENSP00000377225; -.
DR   iPTMnet; Q14320; -.
DR   MetOSite; Q14320; -.
DR   PhosphoSitePlus; Q14320; -.
DR   BioMuta; FAM50A; -.
DR   DMDM; 12231058; -.
DR   EPD; Q14320; -.
DR   jPOST; Q14320; -.
DR   MassIVE; Q14320; -.
DR   MaxQB; Q14320; -.
DR   PaxDb; Q14320; -.
DR   PeptideAtlas; Q14320; -.
DR   PRIDE; Q14320; -.
DR   ProteomicsDB; 59964; -.
DR   Antibodypedia; 488; 198 antibodies from 29 providers.
DR   DNASU; 9130; -.
DR   Ensembl; ENST00000393600.8; ENSP00000377225.3; ENSG00000071859.15.
DR   GeneID; 9130; -.
DR   KEGG; hsa:9130; -.
DR   MANE-Select; ENST00000393600.8; ENSP00000377225.3; NM_004699.4; NP_004690.1.
DR   UCSC; uc004fll.4; human.
DR   CTD; 9130; -.
DR   DisGeNET; 9130; -.
DR   GeneCards; FAM50A; -.
DR   HGNC; HGNC:18786; FAM50A.
DR   HPA; ENSG00000071859; Low tissue specificity.
DR   MalaCards; FAM50A; -.
DR   MIM; 300261; phenotype.
DR   MIM; 300453; gene.
DR   neXtProt; NX_Q14320; -.
DR   OpenTargets; ENSG00000071859; -.
DR   PharmGKB; PA134984709; -.
DR   VEuPathDB; HostDB:ENSG00000071859; -.
DR   eggNOG; KOG2894; Eukaryota.
DR   GeneTree; ENSGT00390000004735; -.
DR   HOGENOM; CLU_037985_1_1_1; -.
DR   InParanoid; Q14320; -.
DR   OMA; DFIWVFL; -.
DR   OrthoDB; 1061864at2759; -.
DR   PhylomeDB; Q14320; -.
DR   TreeFam; TF314738; -.
DR   PathwayCommons; Q14320; -.
DR   SignaLink; Q14320; -.
DR   BioGRID-ORCS; 9130; 157 hits in 709 CRISPR screens.
DR   ChiTaRS; FAM50A; human.
DR   GeneWiki; FAM50A; -.
DR   GenomeRNAi; 9130; -.
DR   Pharos; Q14320; Tbio.
DR   PRO; PR:Q14320; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   RNAct; Q14320; protein.
DR   Bgee; ENSG00000071859; Expressed in sural nerve and 190 other tissues.
DR   ExpressionAtlas; Q14320; baseline and differential.
DR   Genevisible; Q14320; HS.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0006325; P:chromatin organization; IBA:GO_Central.
DR   GO; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW.
DR   GO; GO:0043484; P:regulation of RNA splicing; IMP:UniProtKB.
DR   GO; GO:0008380; P:RNA splicing; IEA:UniProtKB-KW.
DR   GO; GO:0007283; P:spermatogenesis; NAS:UniProtKB.
DR   InterPro; IPR007005; XAP5.
DR   PANTHER; PTHR12722; PTHR12722; 1.
DR   Pfam; PF04921; XAP5; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Direct protein sequencing; Disease variant;
KW   Intellectual disability; Isopeptide bond; mRNA processing; mRNA splicing;
KW   Nucleus; Reference proteome; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   CHAIN           2..339
FT                   /note="Protein FAM50A"
FT                   /id="PRO_0000068284"
FT   REGION          1..31
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          121..177
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           152..155
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        14..31
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        125..143
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        144..177
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   CROSSLNK        100
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   VARIANT         137
FT                   /note="A -> V (likely benign variant; it rescues
FT                   craniofacial patterning defects in zebrafish morphant
FT                   embryos; dbSNP:rs149558328)"
FT                   /evidence="ECO:0000269|PubMed:32703943"
FT                   /id="VAR_084563"
FT   VARIANT         143
FT                   /note="E -> K (likely benign variant; it rescues
FT                   craniofacial patterning defects in zebrafish morphant
FT                   embryos; dbSNP:rs782017549)"
FT                   /evidence="ECO:0000269|PubMed:32703943"
FT                   /id="VAR_084564"
FT   VARIANT         206
FT                   /note="W -> G (in MRXSA; unknown pathological significance;
FT                   does not affect FAM50A protein levels in patient cells;
FT                   does not affect localization to the nucleus)"
FT                   /evidence="ECO:0000269|PubMed:32703943"
FT                   /id="VAR_084565"
FT   VARIANT         254
FT                   /note="E -> G (in MRXSA; hypomorphic variant; does not
FT                   fully rescue craniofacial patterning defects in zebrafish
FT                   morphant embryos; does not affect FAM50A protein levels in
FT                   patient cells; does not affect localization to the
FT                   nucleus)"
FT                   /evidence="ECO:0000269|PubMed:32703943"
FT                   /id="VAR_084566"
FT   VARIANT         255
FT                   /note="D -> G (in MRXSA; hypomorphic variant; does not
FT                   fully rescue craniofacial patterning defects in zebrafish
FT                   morphant embryos; does not affect localization to the
FT                   nucleus)"
FT                   /evidence="ECO:0000269|PubMed:32703943"
FT                   /id="VAR_084567"
FT   VARIANT         255
FT                   /note="D -> N (in MRXSA; hypomorphic variant; does not
FT                   fully rescue craniofacial patterning defects in zebrafish
FT                   morphant embryos)"
FT                   /evidence="ECO:0000269|PubMed:32703943"
FT                   /id="VAR_084568"
FT   VARIANT         273
FT                   /note="R -> W (in MRXSA; hypomorphic variant; does not
FT                   fully rescue craniofacial patterning defects in zebrafish
FT                   morphant embryos)"
FT                   /evidence="ECO:0000269|PubMed:32703943"
FT                   /id="VAR_084569"
FT   CONFLICT        166
FT                   /note="F -> S (in Ref. 2; BAF85808)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        330
FT                   /note="E -> G (in Ref. 2; BAF85808)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   339 AA;  40242 MW;  88BCA57E49B0AA32 CRC64;
     MAQYKGAASE AGRAMHLMKK REKQREQMEQ MKQRIAEENI MKSNIDKKFS AHYDAVEAEL
     KSSTVGLVTL NDMKAKQEAL VKEREKQLAK KEQSKELQMK LEKLREKERK KEAKRKISSL
     SFTLEEEEEG GEEEEEAAMY EEEMEREEIT TKKRKLGKNP DVDTSFLPDR DREEEENRLR
     EELRQEWEAK QEKIKSEEIE ITFSYWDGSG HRRTVKMRKG NTMQQFLQKA LEILRKDFSE
     LRSAGVEQLM YIKEDLIIPH HHSFYDFIVT KARGKSGPLF NFDVHDDVRL LSDATVEKDE
     SHAGKVVLRS WYEKNKHIFP ASRWEPYDPE KKWDKYTIR
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024